The regulator is mulling hiking maximum age to join NPS to 70 years, while exit age may also be revised to 75 years.

The Centre is providing financial support as grant to vaccine manufacturing facilities to enhance their production capacities.

Prime Minister Modi was also briefed about India's production capacity and how it can be enhanced to meet the rising demand. He told officials to increase oxygen production as per the capacity of each plant and offer the surplus stock in steel plants for medical use

Mocking the Central Government's COVID-19 strategy, he called the nationwide lockdown imposed by the Centre on March 25, 2020, a \"Tuglhlaqi lockdown\". The nationwide lockdown had resulted in thousands of migrants fleeing to their homes, many of them barefoot

Cupertino giant Apple on Thursday, April 15, announced a first-of-its-kind carbon removal initiative called 'Restore Fund'; The Centre has given its nod to Mumbai-based Haffkine Institute to manufacture Bharat Biotech's COVID-19 vaccine Covaxin; The Arvind Kejriwal-led Delhi government on Thursday announced fresh curbs, including weekend curfew, to tackle the rise in COVID-19 cases in the national capital; Delhi has left country's financial capital Mumbai, which at one point was the largest COVID-19 hotspot in the country, far behind in terms of daily coronavirus cases and is now the worst-affected city in the country. Watch this and more news on News Blast.

Apple announces first-ever $200 million carbon removal initiative Cupertino giant Apple on Thursday, April 15, announced a first-of-its-kind carbon removal initiative called 'Restore Fund'. Under this new initiative investments will be made in forestry projects to remove carbon from the atmosphere. The new initiative is part of Apple's broader goal of becoming carbon neutral across its entire value chain by 2 COVID-19 vaccine: Centre permits Mumbai's Haffkine Institute to produce Covaxin...

In a letter to Maharashtra Chief Secretary Sitaram Kunte, Renu Swarup, Secretary in Department of Biotechnology, said Haffkine Institute can manufacture the vaccine doses.

Medical oxygen sources have been mapped for 12 high-burden states and 50,000 MT of medical oxygen would be imported to deal with the increased demand.

The last year was an extremely challenging year because of COVID-19 restrictions, but still there has been growth of around 23 per cent in the subscriber numbers, PFRDA Chairman Supratim Bandyopadhyay told reporters

Air India looking to hire CEOs for its subsidiaries National carrier Air India has sought applications for the post of chief executive officer (CEO) for its subsidiaries Air India Engineering Services Ltd (AIESL), Air India Airport Services Ltd (AIASL) and Alliance Air Aviation Ltd (AAAL). The selected candidates will be hired for a contract period of three years, extendable by two years based on performance.Flipkart to take over Cleartrip in distress saleFlipkart will acquire embattled t...

Addressing a virtual press briefing on April 13, Dmitriev said its vaccine partnership covers 20 producers in 10 countries including Korea, China and India

The company has got permission from the Drug Controller General of India (DCGI) to import the vaccine. Reddy's is also going to tap domestically contract manufactured vaccines as and when companies are allowed to start commercial manufacturing in India

The amount/ pension received under APY is treated as taxable income. The beneficiary would be taxed as per applicable income tax slab

Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.

Coronavirus vaccination: After taking the first shot, the vaccine beneficiary will receive a message on his/her registered mobile number about the link to download the vaccination certificate

How to minimise interest rate, credit and liquidity risks in debt funds

Drug major Dr Reddy's Laboratories is also going to tap domestically sourced jabs as their production speeds up in India

Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses

Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year

India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year